(Q44070976)

English

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group (English)

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Adaptive radiation therapy

0 references

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

Mitchell Machtay

1

object named as

Mitchell Machtay

1 reference

Europe PubMed Central

21 February 2018

6

object named as

Ritsuko Komaki

1 reference

Europe PubMed Central

21 February 2018

author name string

Kyounghwa Bae

2

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Benjamin Movsas

3

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Rebecca Paulus

4

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Elizabeth M Gore

5

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Kathy Albain

7

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

William T Sause

8

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Walter J Curran

9

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

language of work or name

0 references

publication date

25 October 2010

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

82

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

1

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

425-434

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

25 May 2018

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

25 May 2018

Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

25 May 2018

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

25 May 2018

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

25 May 2018

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-sm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Non-small cell lung tumors repopulate rapidly during radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5764542

15 August 2018

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980108

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2010.09.004

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

1 reference

Europe PubMed Central

21 February 2018

http://europepmc.org/abstract/PMC/5764542

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44070976&oldid=2106256290"